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ABSTRACT Gram-negativeoutermembrane(OM)integrityismaintainedinpartbyMg2cross-linksbetweenphosphateson
lipidAandoncoresugarsofadjacentlipopolysaccharide(LPS)molecules.IncontrasttootherGram-negativebacteria, waaP,
encoding an inner-core kinase, could not be inactivated in Pseudomonas aeruginosa. To examine this further, expression of the
kinasesWaaPorWapP/WapQ/PA5006wasplacedunderthecontrolofthearabinose-regulatedpBADpromoter.Growthof
these strains was arabinose dependent, conﬁrming that core phosphorylation is essential in P. aeruginosa. Transmission elec-
tronmicrographsofkinase-depletedcellsrevealedmarkedinvaginationsoftheinnermembrane.SDS-PAGEoftotalLPSfrom
WaaP-depletedcellsshowedaccumulationofafast-migratingband.Massspectrometry(MS)analysisrevealedthatLPSfrom
thesecellsexhibitsauniquetruncatedcoreconsistingoftwo3-deoxy-D-manno-octulosonicacids(Kdo),two L-glycero-D-
manno-heptoses(Hep),andonehexosebutcompletelydevoidofphosphates,indicatingthatphosphorylationbyWaaPisneces-
saryforsubsequentcorephosphorylations.MSanalysisoflipidAfromWaaP-depletedcellsrevealedextensive4-amino-4-
deoxy-L-arabinosemodiﬁcation.OMpreparedfromthesecellsbySarkosylextractionoftotalmembranesorbysucrosedensity
gradientcentrifugationlackedtruncatedLPS.Instead,truncatedLPSwasdetectedintheinnermembranefractions,consistent
withimpairedtransport/assemblyofthisspeciesintotheOM.
IMPORTANCE Gram-negativebacteriahaveanoutermembrane(OM)comprisedofaphospholipidinnerleaﬂetandalipopoly-
saccharide(LPS)outerleaﬂet.TheOMprotectscellsfromtoxicmoleculesandisimportantforsurvivalduringinfection.The
LPS core kinase gene waaP can be deleted in several Gram-negative bacteria but not in Pseudomonas aeruginosa. We used a
controlled-expression system to deplete WaaP directly in P. aeruginosa cells, which halted growth. WaaP depletion also caused
grosschangesincellmorphologyandledtotheaccumulationofanaberrantLPSlackingseveralcoresugarsandallcorephos-
phates. The aberrant LPS failed to reach the OM, suggesting that WaaP is essential in P. aeruginosa because it is required to pro-
ducethefull-lengthLPSthatisrecognizedbytheOMtransport/assemblymachineryinthisorganism.Therefore,WaaPmay
constituteagoodtargetforthedevelopmentofnovelantipseudomonalagents.
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P
seudomonas aeruginosa is the third most common agent of
nosocomial infections in the United States (1) and is associ-
atedwithavarietyofinfections,perhapsmostnotablyinthelungs
ofthosewithcysticﬁbrosis(2).P.aeruginosaalsoexhibitsintrinsic
resistance to antibiotics, mediated in part by its comparatively
impermeable outer membrane (OM) working in conjunction
withmultipleefﬂuxpumps(3).OptionsfortreatingP.aeruginosa
infectionsarelimitedandbecominglesseffectiveduetoincreased
antibiotic resistance (4, 5), necessitating the development of new
antimicrobials. The intrinsic resistance engendered by efﬂux/OM
also severely hampers the identiﬁcation and development of new
antibiotics with sufﬁcient whole-cell potency to be clinically use-
ful. One approach to this has been to target the synthesis of lipo-
polysaccharide (LPS), the major component deﬁning the OM.
Targeting OM biogenesis is attractive because the OM is essential
for viability and mediates virulence as well as resistance to toxic
agentsandantibacterials(6,7).TheOMisanasymmetricbilayer,
with a phospholipid inner leaﬂet and an LPS outer leaﬂet. The
basic structure of LPS (reviewed in references 8 and 9; also see
Fig. S1 in the supplemental material) includes a relatively con-
served molecule of the membrane anchor lipid A (endotoxin),
covalently attached to a more variable polysaccharide unit, com-
posed of two independently synthesized carbohydrate regions.
These are the core oligosaccharide and the O-antigen repeating
unit, which extend outward from the cell surface. Potent inhibi-
tors of LpxC, involved in lipid A biosynthesis, that have antibac-
terial activity against P. aeruginosa have been identiﬁed (10–12).
BiosynthesisofLPSitselfiswellunderstood,buttherehasbeen
recent interest in dissecting the downstream mechanisms for
transport and assembly of LPS into the outer leaﬂet of the OM (9,
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lipid A-core, synthesized on the inner leaﬂet of the inner mem-
brane (IM), is ﬂipped across the IM by the ATP-binding cassette
(ABC)transporterMsbA(16,17).Ontheperiplasmicside,LPSis
ﬁrst extracted from the outer leaﬂet of the IM by LptC in coordi-
nation with the LptBFG transporter complex and then conveyed
by the periplasmic protein LptA to the LptDE complex, which
inserts fully assembled LPS to the outer leaﬂet of the OM through
anas-yet-uncharacterizedprocess(13,18).Thetransportersstud-
ied to date are essential for viability in Escherichia coli, and their
downregulation leads to morphological changes consistent with
interruption of LPS transport/assembly (15, 19, 20). Coincident
with the improved understanding of the LPS transport/assembly
process, a recent report (21) described a peptide-based inhibitor
of LptD with very potent cellular activity against P. aeruginosa.
OM integrity is maintained in part by cross-linking of LPS
between negative charges of phosphates on lipid A and inner core
with Mg2 ions (22, 23). The ﬁrst L-glycero-D-manno-heptose
(HepI) residue of the inner core in E. coli and Salmonella enterica
LPS contains a single phosphate at the O-4 position that is not
essential for growth. However, deletion of the gene encoding the
WaaP (previously RfaP) kinase responsible for addition of this
phosphate engenders the so-called deep-rough phenotype (24–
26),typicalofthatcausedbymutationallossofinner-coresugars.
This phenotype includes hypersensitivity to hydrophobic antibi-
oticsandlossofvirulence,reﬂectingdisruptionoftheOMperme-
ability barrier (22). WaaP phosphorylates nascent lipid A-core at
the cytoplasmic side of the IM prior to MsbA-mediated transport
of lipid A-core to the periplasmic side of the IM (27, 28).
The inner core of P. aeruginosa LPS (see Fig. S1 in the supple-
mentalmaterial)isheavilyphosphorylated,with3to6phosphates
(29, 30). Reﬂecting this, P. aeruginosa waaP occurs within a gene
cluster containing LPS sugar transferase genes waaF, waaC, and
wapG;twootherLPSkinasegenes,wapPandwapQ;andaputative
LPSkinasegene,PA5006(8,23)(Fig.1A).IncontrasttoE.coliand
S. enterica, waaP and wapP were inferred to be essential, based on
an inability to inactivate either gene in P. aeruginosa (23). P.
aeruginosawaaPcanmediatethephosphorylationoftheHepIO-4
position when introduced into a Salmonella waaP-knockout
strain (23). The second essential HepI phosphate of P. aeruginosa
LPS is thought to be added by WapP (23, 28). Transformation of
eitherwaaPorwapPintoaSalmonellawaaP-knockoutstraindra-
matically increased resistance to sodium dodecyl sulfate (SDS)
and novobiocin (23), consistent with LPS core phosphorylation.
The inability to create genetic deletions of waaP in P. aeruginosa
suggested a role for LPS phosphorylation beyond OM cross-
linking,butitsrequirementforviabilityprecludedfurtherstudies
in P. aeruginosa. Here, we employed an arabinose-inducible ex-
pression system (pBAD) to characterize the cellular impact of de-
pletion of WaaP and WapP/WapQ/PA5006 directly in the native
P. aeruginosa PAO1 (K767) background.
RESULTS
WaaPisessentialforgrowthinP.aeruginosaPAO1.Tocharac-
terize the role of inner-core kinases of P. aeruginosa PAO1, we
regulated the expression of waaP (CDR0031) and wapP/wapQ/
PA5006 (CDR0060) using an arabinose-inducible promoter sys-
tem (pBAD) in a single copy on the chromosome. Growth of
strains CDR0031 and CDR0060 required supplementation of the
medium with L-arabinose (Fig. 2), directly demonstrating that
WaaPandatleastoneotherkinase(WapP,WapQ,orPA5006)are
essential for growth in P. aeruginosa. A genetic knockout of wapQ
was reported, while attempts to inactivate WapP proved unsuc-
FIG 1 Genetic organization of waaP in wild type, CDR0031, and CDR0060. (A) The four proposed LPS kinase genes waaP, wapP, wapQ, and PA5006 are
annotatedasasingleoperonamongotherLPSsynthesisgenesinP.aeruginosaPAO1.(BandC)Geneticarrangementofarabinose-regulatedLPSkinasestrains;
the arabinose promoter (pBAD) controls expression of waaP in strain CDR0031 (B) and expression of wapP, wapQ, and PA5006 in strain CDR0060 (C). The
arabinose-regulatedcopyofwaaPinCDR0031wasinsertedatanonessentialchromosomalattsite,andthenativecopyofwaaPwasinsertionallyinactivatedby
agentamicinresistancecartridge.ExpressionofwaaPinCDR0060iscontrolledbyitsnativepromoterupstreamofwaaFasinpanelA,andasecondwaaPcopy,
generated by pBAD18M2 integration into the chromosome, is arabinose controlled.
FIG 2 Growth of CDR0031 and CDR0060 is dependent on L-arabinose.
Growth of wild-type PAO1 and L-arabinose-controlled-expression waaP
(CDR0031) and wapP/wapQ/PA5006 (CDR0060) strains was measured by
monitoring OD600 after their subculture with () and without () 0.2%
L-arabinose. Strains CDR0031 and CDR0060 cultured with L-arabinose grow
slightlyslowerthanwild-typePAO1,suggestingthatwild-typeexpressionlev-
els of waaP or wapP/wapQ/PA5006 were not achieved with full induction.
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sulted from loss of WapP. However, some contribution to viabil-
ity might be provided from the putative kinase PA5006.
Core kinase depletion causes accumulation of LPS having a
truncated core. When cultured without L-arabinose, strains
CDR0031 and CDR0060 stopped growing after several genera-
tions, allowing isolation of kinase-depleted cells that presumably
accumulate LPS lacking one or more core HepI phosphates. Total
LPS isolated from kinase-depleted cells had an additional band of
LPS compared to wild-type LPS (Fig. 3A, lanes 3 and 5). These
species migrated faster than did the wild-type lipid A-core band
and slightly slower than the truncated lipid A-core band of a de-
ﬁned P. aeruginosa galU knockout (Fig. 3A, lane 6). GalU is the
glucose-1-phosphate uridylyl transferase needed to synthesize
UDP-glucose.Correspondingly,LPSfromthegalUmutanttermi-
nates at the galactosamine residue due to loss of the distal outer-
coreglucosesdepictedinFig.S1inthesupplementalmaterial(29,
31). The truncated LPS species observed from WapP/WapQ/
PA5006 depletion (CDR0060) migrated slightly faster than that
from WaaP depletion (CDR0031; compare lanes 3= and 5= in
Fig. 3A).
To determine whether the truncated LPS from the WaaP-
depleted strain lacked the HepI 4-phosphate, puriﬁed P. aerugi-
nosa WaaP kinase and [-33P]ATP were incubated with the total
LPS isolated from strain CDR0031. A strong 33P-labeled band
(Fig.3B)wasobservedatthepositionofthetruncatedLPSspecies
(Fig.3A,lane3),suggestingthatonlythetruncatedLPSlackedthe
HepI 4-phosphate normally added by WaaP. We observed no 33P
incorporation with the truncated LPS derived from CDR0060 in
the in vitro WaaP reaction, consistent with this species already
having the HepI 4-phosphate.
Truncated LPS with unphosphorylated core is not trans-
ported to the OM. Since WaaP is uniquely essential in P. aerugi-
nosa, we surmised that truncated LPS lacking core phosphates
might not be recognized by downstream transport/assembly ma-
chineryandwouldfailtoreachtheOM.Supportingthis,LPSfrom
OM prepared by Sarkosyl extraction of total membranes lacked
the truncated LPS bands (Fig. 4A). Sucrose density gradient sep-
aration of the IM and OM conﬁrmed that the truncated LPS spe-
cies for both kinase-depleted strains were localized primarily in
theIMfraction(Fig.4B).AfaintbandoftruncatedLPSwasvisible
in OM fractions from both procedures when the LPS sample was
overloaded. This may represent low levels of transport of trun-
cated LPS to the OM and/or minor contamination of IM in the
OM preparation. Nonetheless, the presence of the truncated LPS
overwhelmingly in the IM fraction implies failure of the down-
stream LPS transport machinery to recognize this species.
Cellular depletion of core kinases leads to an abnormal IM.
Cells depleted of WaaP or WapP/WapQ/PA5006 revealed gross
morphological defects, including severe IM invaginations (stan-
dard transmission electron microscopy [TEM] [Fig. 5] and high-
pressure-freeze [HPF]-substitution TEM [see Fig. S2 in the sup-
plemental material]). The IM invaginations form large
membrane-boundor“vacuole-like”compartmentsthatappearto
contain periplasmic material, reminiscent of plasmolysis induced
by severe osmotic shock (32, 33). It is noteworthy that the kinase-
depletedcellswereisolateddirectlyfromrichgrowthmediumand
immediately ﬁxed or processed for freeze substitution. The cells
were not exposed to conditions of osmotic shock, and the similar
images obtained using two different electron microscopy (EM)
techniques suggest that this phenomenon is not an artifact of EM
preparative procedures.
Identiﬁcation of truncated LPS core species from kinase-
depletedcells.TocharacterizethetruncatedLPSspeciesaccumu-
lating in strains depleted of core kinase activity, LPS was isolated
from the IM fractions obtained from wild-type PAO1, WaaP-
depleted (CDR0031), and WapP/WapQ/PA5006-depleted
(CDR0060) cells. Core oligosaccharides were isolated and ana-
lyzedbyelectrosprayionizationmassspectrometry(ESI-MS).For
wild-type PAO1, CDR0031, and CDR0060 LPS, core peaks con-
sistent with the expected uncapped-core glycoforms (8, 30, 34)
were detected (see Table S1 and Fig. S3 in the supplemental ma-
terial). The peaks were consistent with the [M-2H]2 and [M-3H
 Na]2 ions of the expected wild-type LPS cores lacking O anti-
gen (Table S1). The mass-to-charge ratio (m/z) values of most
peaks were consistent with Rha-Glc4-GalN(Ala)-Hep(Cm)-Hep-
Kdo(CmiscarbamoylandKdois3-deoxy-D-manno-octulosonic
acid)witharangeof2to5phosphates.Theabsenceofphosphoe-
thanolamine is consistent with the LPS isolation procedure used
as noted previously (29). The detection of core in the IM fraction
of wild-type PAO1 is consistent with Fig. 4B.
The ESI-MS spectrum for core isolated from WaaP-depleted,
IM-derived LPS (enriched for the truncated species) had major
novelpeaksatm/z783.2and765.2(Table1;seealsoFig.S3Binthe
supplemental material). The exact masses of these singly-charged
FIG 3 LPS derived from CDR0031 and CDR0060 contains truncated LPS.
(A) Total LPS was isolated and visualized by silver staining after SDS-PAGE.
Lane 1, wild-type PAO1; lane 2, CDR0031  Ara; lanes 3 and 3=, CDR0031
(Ara, WaaP-depleted); lane 4, CDR0060  Ara; lanes 5 and 5=, CDR0060
(Ara,WapP/WapQ/PA5006-depleted);lane6,galUknockout(PAO1).Note
the accumulation of truncated LPS species (*, lanes 3 and 5) when waaP or
wapP/wapQ/PA5006wasdownregulated(Ara).(B)WaaPkinase(lanes2,4,
and 6) and control (lanes 1, 3, and 5) reaction mixtures with total LPS and
[-33P]ATP. Lanes 1 and 2, wild-type PAO1 LPS; lanes 3 and 4, CDR0031
(Ara, WaaP-depleted) LPS; lanes 5 and 6, CDR0060 (Ara, WapP/WapQ/
PA5006-depleted) LPS.
FIG 4 Truncated LPS of CDR0031 and CDR0060 is localized to the IM.
SDS-PAGE of LPS isolated from Sarkosyl-extracted OM (A) or from IM and
OMfractions(B).(A)Lane1,wild-typePAO1;lane2,CDR0031Ara;lane3,
CDR0031 (Ara, WaaP-depleted); lane 4, CDR0060  Ara; lane 5, CDR0060
(Ara,WapP/WapQ/PA5006-depleted).(B)Lane1,wild-typePAO1IMLPS;
lane 2, wild-type PAO1 OM LPS; lane 3, CDR0031 IM LPS (Ara, WaaP-
depleted); lane 4, CDR0031 OM LPS (Ara, WaaP-depleted); lane 5,
CDR0060 IM LPS (Ara, WapP/WapQ/PA5006-depleted); lane 6, CDR0060
OM LPS (Ara, WapP/WapQ/PA5006-depleted).
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cated core: Hex-Hep2-Kdo and its anhydro-Kdo derivative, re-
spectively (35). Assuming the presence of two Kdo units before
hydrolysis,thisputativepentasaccharidecorelacksallphosphates.
The carbamate and alanine moieties present on wild-type and
galUmutantcore(TableS1)(8,29)arealsoabsent.Theproposed
core composition of Hex-Hep2-Kdo also indicates that the outer-
coregalactosamine(GalN),usuallylinkedtoHepII,ismissingand
an as-yet-unidentiﬁed hexose is present in the core. The identity,
linkage analysis, and anomeric conﬁguration of this hexose re-
maintobedetermined.Minornovelpeaksatm/z853.3and835.3
werealsodetected(Table1;seealsoFig.S3B).Theexactmassesof
thesesingly-chargedspeciesareconsistentwiththe[M-H]ionof
theuniquetruncatedcore:GalN(Ala)-Hep2-Kdoanditsanhydro-
Kdoderivative,respectively.Thisminorpentasaccharidecorealso
lacks all phosphates and carbamate moieties.
ESI-MSexaminationofIM-derivedLPScoreisolatedfromthe
wapP/wapQ/PA5006-downregulated strain CDR0060 (Table 1;
see also Fig. S3C in the supplemental material) revealed peaks
consistent with truncated cores with compositions of GalN(Ala)-
HepII(Cm)-HepI-P-Kdo and GalN(Ala)-HepII(Cm)-HepI-P2-
Kdo (and their corresponding anhydro-Kdo derivatives). These
species are similar to those observed in the galU mutant (29) ex-
cept with only 1 or 2 core phosphates, instead of 3 to 6. The pres-
ence of phosphates in the core suggests that WaaP is active in the
CDR0060 background. The second core phosphate present could
reﬂect nonuniform downregulation of the three kinases in this
strain or phosphorylation by an unidentiﬁed kinase. The addi-
tional negative charge(s) may explain the faster migration of the
truncated LPS from strain CDR0060 compared to that from
CDR0031 (Fig. 3A). Unexpectedly, the major nonphosphory-
lated, truncated core species seen upon WaaP depletion (see
above) were also seen here (Table 1; see also Fig. S3C), and this
remains unexplained.
KinasedepletioninduceslipidAmodiﬁcation.Toseeiflipid
A modiﬁcation systems are activated upon WaaP depletion, lipid
A was isolated from wild-type PAO1 and WaaP-depleted
CDR0031cellsandanalyzedbyESI-MS.Wild-typePAO1LPS(see
Fig. S4A in the supplemental material) had both penta-acylated
species (m/z 722.5 and 730.5) and hexa-acylated species (m/z
807.6 and 815.6) as expected (8) (see also Fig. S5). Interestingly,
loss of WaaP leads to modiﬁcation of the lipid A species by
4-amino-4-deoxy-L-arabinose (L-Ara4N), singly and doubly
(Fig. S4B), at the 1- and/or 4=-phosphate of the lipid A digluco-
saminebackbone(Fig.S5).ThismodiﬁcationismediatedbyArnT
on the periplasmic leaﬂet of the IM (8). Modiﬁcation was also
observed for WapP/WapQ/PA5006-depleted cells (data not
shown). Although decreases in OM stability/lipid perturbations
have been shown to lead to secondary acylation (palmitate addi-
tion) of lipid A (21, 36), data from ESI-MS analysis showed no
signiﬁcant differences in acylation between wild-type and WaaP-
depleted cells.
IM and OM phospholipid and lipid A analysis. IM and OM
samples from wild-type and WaaP-depleted cells have similar
amounts of normal LPS (Fig. 4B), with the additional truncated
speciespresentonlyintheIMfromstrainCDR0031.Thepresence
of penta-acylated lipid A in the IM fraction (see Fig. S6A in the
supplemental material) is diagnostic of OM contamination be-
FIG 5 Morphological changes to P. aeruginosa cells upon depletion of LPS core kinases. Cells were examined by standard TEM. (A) Wild-type PAO1; (B)
CDR0031 (Ara, WaaP-depleted); (C) CDR0060 (Ara, WapP/WapQ/PA5006-depleted). Severe perturbations (lengthening and invaginations) of the IM
(indicated by arrows) were observed for WaaP- and WapP/WapQ/PA5006-depleted cells, consistent with accumulation of truncated LPS which is not exported
to the OM.
TABLE 1 Observed masses and proposed compositions for truncated cores observed by ESI-MS
Strain Proposed structureb Calculated m/z Observed m/za
CDR0031 (WaaP-depleted) [HexHep2Kdo-H] 783.24 783.2
[HexHep2anhydroKdo-H] 765.23 765.2
[GalN(Ala)Hep2Kdo-H] 853.29 853.3
[GalN(Ala)Hep2anhydroKdo-H] 835.28 835.3
CDR0060 (WapP/WapQ/PA5006-depleted) [HexHep2Kdo-H] 783.24 783.2
[HexHep2anhydroKdo-H] 765.23 765.2
[GalN(Ala)Hep(Cm)HepPKdo-H] 976.27 976.3
[GalN(Ala)Hep(Cm)HepPKdo-2H]2 487.63 487.6c
[GalN(Ala)Hep(Cm)HepPanhydroKdo-H] 958.26 958.3
[GalN(Ala)Hep(Cm)HepPanhydroKdo-2H]2 478.62 478.6c
[GalN(Ala)Hep(Cm)HepP2Kdo-2H]2 527.61 527.6
[GalN(Ala)Hep(Cm)HepP2anhydroKdo-2H]2 518.61 518.6
a Peaks identiﬁed by negative-ion ESI-MS with an m/z scan (60 to 2,200) were subject to enhanced-resolution ESI-MS to determine exact mass and charge state (data not shown).
Only assignable peaks with unambiguous exact masses and charge states are listed.
b A second Kdo residue, which is cleaved as a result of acid hydrolysis during core preparation (35), would be present in the intact core.
c Peaks observed by enhanced-resolution ESI-MS but not shown in Fig. S3C in the supplemental material.
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PagL(8,37).ESI-MSspectraforlipidAfromWaaP-depletedcells
showedasigniﬁcantamountof L-Ara4N-modiﬁedlipidAinboth
IM and OM fractions (Fig. S6). Therefore, L-Ara4N modiﬁcation
is not speciﬁc to the truncated LPS localized in the IM fraction.
The WaaP-deﬁcient cells should have more LPS in their IM frac-
tions than should the wild-type cells, due to the presence of the
additional truncated LPS species. Reﬂecting this, the ratio of lipid
AtophospholipidintheIMislargerforWaaP-depletedcellsthan
for wild-type cells (Fig. S6A); however, the IM did not have a
comparatively lower fraction of L-Ara4N-modiﬁed lipid A, sug-
gesting that the truncated LPS was also L-Ara4N modiﬁed at the
periplasmic leaﬂet of the IM.
Effect of core kinase depletion on EDTA and antibiotic sus-
ceptibility. To see if depletion of WaaP compromised the OM in
P. aeruginosa, we tested the susceptibilities of CDR0031 and
CDR0060toEDTA,thehydrophobicantibioticnovobiocin,anda
polycationic antimicrobial peptide, polymyxin B, in media sup-
plementedwithhigh(0.2%)orlow(0.04%) L-arabinose(Table2).
CDR0031 supplemented with low L-arabinose was 32-fold more
sensitive to EDTA and 4-fold more sensitive to novobiocin than
waswild-typePAO1.Wild-typesusceptibilitytobothcompounds
was restored with addition of 0.2% L-arabinose. We also noted an
increase in sensitivity to polymyxin B (ca. 16-fold) upon waaP
downregulation in P. aeruginosa. Strain CDR0060 also became
moresusceptibletoantibioticsunderlow-L-arabinoseconditions;
however,thiseffectappearedtobelesspronouncedthanforstrain
CDR0031.
DISCUSSION
Phosphorylation of the LPS inner core by WaaP is important for
maintaining the OM permeability barrier of E. coli and S. enterica
(23, 25, 26). Loss of waaP in E. coli R1 strain F470 (lacking O
antigen) and in S. enterica also caused loss of HepIII, loss of inner-
core phosphates on HepI and HepII, and decreased efﬁciency in
O-antigenattachment(S.enterica)(25,26).Alteredcorestructure
and reduced O-antigen attachment were also reported for
transposon-mediated disruption of waaP in Shigella ﬂexneri (38).
These waaP mutants were, however, viable, and for S. enterica,
production of full-length LPS was noted without a growth defect
(25).Incontrast,attemptstoinactivatewaaPinP.aeruginosawere
unsuccessful (23). Here, we show directly that WaaP is essential
for growth using a recombinant P. aeruginosa strain harboring an
L-arabinose-inducible waaP gene. This allowed the depletion of
WaaP, which caused the accumulation of a truncated species of
LPS. MS analysis of core showed that loss of WaaP prevents all
corephosphorylationandblockscompletionoffull-lengthcore.It
was suggested that the P. aeruginosa OM was uniquely dependent
on maintaining LPS cross-links and that their loss would destabi-
lize the membrane of P. aeruginosa, accounting for the essential
nature of WaaP (23). However, our data support an alternative
explanation, i.e., that the altered LPS produced in the absence of
WaaP is not recognized by the LPS transport and OM assembly
machinery. EM images of these cells revealed gross changes to the
IM, consistent with a defect in LPS trafﬁcking or, alternatively,
continued synthesis of IM (containing the aberrant LPS) after
cessation of OM synthesis. Similar observations with a strain
downregulated for WapP/WapQ/PA5006 suggest that the HepI
4-phosphate transferred by WaaP may not be the speciﬁc factor
mediating recognition by the transport machinery. Nonetheless,
ourdataclearlyshowedthatWaaPisaprerequisiteforsynthesisof
efﬁciently transportable LPS in P. aeruginosa.
The P. aeruginosa OM is less permeable than that of other
Gram-negative bacteria (39). It is difﬁcult to assess the direct im-
pact of WaaP depletion on the OM itself, which appears largely
intact in several cells examined by EM. However, loss of WaaP
appears to increase sensitivity to the hydrophobic antibiotic no-
vobiocin (Table 2). This increase is relatively small compared to
that reported for waaP genetic knockouts created in E. coli and
S. enterica (23, 25, 26, 28), but this may reﬂect partial WaaP loss
due to downregulation. Sensitivity to EDTA may result from a
general defect in new LPS reaching the OM, providing less cross-
linked LPS overall, increasing susceptibility to Mg2 chelation.
Reduction in LPS negative charge via L-Ara4N decoration of
the lipid A moiety has been linked to reduced susceptibility to
cationic peptides, including polymyxin B (40). Lipid A from an S.
enterica waaP knockout lacked L-Ara4N modiﬁcation (25),
whereas we show that lipid A from the WaaP-depleted P. aerugi-
nosa cells was modiﬁed. Susceptibility to polymyxin B was in-
creased in both cases, suggesting that any contribution of lipid A
modiﬁcation to polymyxin resistance in P. aeruginosa is out-
weighed by the loss of core phosphates. Perhaps consistent with
this, the membrane-defective hypersusceptible P. aeruginosa
strain Z61 also had L-Ara4N modiﬁcation of the LPS and in-
creased susceptibility to polymyxin B (41).
The precise location of the aberrant LPS resulting from loss of
core phosphates is not known. There is no obvious accumulation
of membranous material in the periplasm in our EM images as
observed for E. coli strains downregulated for Lpt components
(15) and for P. aeruginosa cells treated with an inhibitor of LptD
(21).ThetruncatedLPSwasisolatedprimarilyintheIMfraction,
and the apparent lengthening of the IM is more consistent with
speciﬁc IM localization. P. aeruginosa lipid A-core chemically
stripped of all phosphates (including the lipid A phosphates)
failed to stimulate the ATPase activity of isolated P. aeruginosa
TABLE 2 MIC determinationsa
Strain
MIC of:
EDTA (mM) Novobiocin (g/ml) Polymyxin B (g/ml)
PAO1 10 625–1,250 0.5–1
CDR0031  0.2% Ara 5–10 625 0.25
CDR0031  0.04% Ara 0.3125–0.625 156 0.03125–0.0625
CDR0060  0.2% Ara 0.625–0.125 625 0.25
CDR0060  0.04% Ara 0.3125–0.625 312–625 0.125
a Values are from at least two determinations. Because of a high frequency of reversion to wild type, MIC testing with the wapP/wapQ/PA5006-regulated strain CDR0060 was
supplemented with 300 g/ml carbenicillin to maintain arabinose-controlled expression of LPS kinases.
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phosphate(s). In our electron micrographs, there was no obvious
blebbingontheinnerleaﬂetoftheIMpreviouslyseenwithMsbA
temperature-sensitive mutants of E. coli (20). This suggests that
theLptBCFGcomplexmaynotrecognizethetruncatedLPS.Fur-
thermore,theevidencefor L-Ara4Nmodiﬁcationofthetruncated
LPS, which is reported to occur at the outer leaﬂet of the IM (40),
impliesthatthisspeciescouldbetrappedintheperiplasmicleaﬂet;
however, the speciﬁc location and the underlying basis for the
proposed LPS transport defect await further investigation.
Taken together, our data indicate that WaaP is necessary for
thecompletionofLPSsynthesisandOMassemblyinP.aeruginosa
and may therefore be a good target for the discovery of novel
therapeutics targeting P. aeruginosa.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth media. All bacterial
strains, plasmids, and primers used in this study are listed in Ta-
bles S2 and S3 in the supplemental material. Lysogeny broth (L
broth)(tryptone,10g/liter;yeastextract,5g/liter;NaCl,10g/liter)
orLagarwasusedforroutinegrowthofE.coliandP.aeruginosaat
37°C unless otherwise speciﬁed. L-Arabinose-dependent strains
CDR0031 (gentamicin resistant) and CDR0060 (carbenicillin re-
sistant)arederivativesofthewild-typeP.aeruginosastrainPAO1.
As necessary, 0.2% L-arabinose and gentamicin (10 g/ml for
E.coliand100g/lforP.aeruginosa),ampicillin(100g/mlfor
E.coli),carbenicillin(300g/lforP.aeruginosa),ortetracycline
(10g/mlforE.colior100g/mlforP.aeruginosa)wereaddedto
growth medium.
DNA manipulations. Oligonucleotides were purchased from
Integrated DNA Technologies, Inc. (Coralville, IA), and DNA se-
quencing was carried out by Agencourt Inc. (Bedford, MA). PCR
was carried out using AccuPrime GC DNA polymerase (Invitro-
gen), Vent DNA polymerase (NEB), or Phusion High-Fidelity
DNA polymerase (NEB), according to the supplier’s instructions.
DNAfragmentswerepuriﬁedusingQIAquickPCRcleanuporgel
extraction kits (Qiagen).
ConstructionofpMini-CTXderivativewithpBAD-waaPex-
pression system. Plasmid pBAD18M2 is a derivative of pBAD18
with an altered ribosome binding site (RBS) and HindIII site ad-
dition to the araC-pBAD promoter segment as described previ-
ously for plasmid pBEM10 (12). The waaP gene was PCR ampli-
ﬁedwithprimerswaaPupHindandwaaPrevXmaI,usingPhusion
DNA polymerase (NEB) to generate blunt ends. This fragment
was digested with HindIII and ligated into pBAD18M2 that had
been cut with XhoI, blunt ended, and then cut with HindIII. The
resultant plasmid pBADM2-waaP had waaP with 132 bp of up-
stream untranslated sequence, placed in the correct orientation
for regulated expression from the pBAD promoter, with an XmaI
site introduced downstream of waaP. A mini-CTX derivative of
the pBAD-regulated waaP construct, for placement on the
P. aeruginosa genome, was then made as follows. Plasmid pRC7
was constructed as a general mini-CTX vector for placing pBAD-
regulated constructs into the genome. For this, the luxCDABE
genes from mini-CTX-lux (42) were removed with SalI-EcoRV
and swapped with an XhoI-HpaI fragment encompassing an
araC-pBADpromoterfragmentderivedfromasyntheticplasmid,
pGA18-pBAD (GeneArt AG, Burlingame, CA). The ﬁnal con-
struct used for placing a regulated copy of waaP into the att site
(pRC8) was made by swapping an EcoRV-XmaI fragment from
pBAD18M2-waaP (encompassing part of araC through waaP)
intothepRC7vectorfromwhichthecorrespondingpartial araC-
pBAD fragment had been removed by digestion with EcoRV and
XmaI.
Construction of the WaaP controlled-expression strain
CDR0031. The pBAD-waaP construct was inserted into the ge-
nome of P. aeruginosa PAO1, using the E. coli mobilizer strain
S17-1, and conﬁrmed as described previously (43, 44). The native
waaP gene was then inactivated as follows: the waaP gene was
generated from PAO1 using primers waaPforHind and waaPre-
vBam, digested with HindIII and BamHI, and ligated into simi-
larlydigestedpEX18Tc(45).TheaacC1gentamicinresistancecar-
tridge (isolated from pUCGm [46] with SalI) was ligated into the
uniqueXhoIsitewithinwaaPinthesameorientationasthewaaP
gene to generate plasmid pRC10. Plasmid pRC10 was used to dis-
ruptwaaPonthegenomeofP.aeruginosaasdescribedpreviously
(47), using the E. coli mobilizer strain S17-1 (44). Recombinants
lacking plasmid backbone were isolated by streaking merodiploid
colonies onto L agar with 5% sucrose, 0.2% L-arabinose, and
100 g/ml gentamicin. Colonies were tested for gentamicin resis-
tance and tetracycline sensitivity. To identify native waaP inacti-
vation, the location of aacC1 was determined using PCR with
primer pairs waaPXhoI and waaPoutr (native) and PaaraC and
PawaaPXho (pBAD regulated). One isolate, CDR0031, had the
aacC1 cartridge within the native waaP copy and retained the
intact pBAD-regulated copy with a 132-bp upstream leader se-
quence (Fig. 1B).
Construction of the WapP/WapQ/PA5006 controlled-
expression strain CDR0060. Strain CDR0060 was constructed
using a procedure based on that reported previously for creation
of a controlled-regulation strain for LpxC (12). Plasmid
pBAD18M2-waaP, described above, was introduced into PAO1
using electroporation (48). Plasmid pBAD18M2-waaP cannot
replicate in P. aeruginosa, and therefore, carbenicillin-resistant
colonies arise from integration of the plasmid into the chromo-
some. Because pBAD18M2-waaP has the entire waaP gene rather
than a partial fragment, it will generate an insertion, leaving the
native copy of waaP intact and having waaP, wapP, wapQ, and
PA5006 under the control of the pBAD promoter (Fig. 1C). Since
the native waaP is preserved, only wapP, wapQ, and PA5006 are
regulated by the pBAD promoter. Putative regulated strains were
identiﬁedbytestingforarabinose-dependentgrowth,andforone
such colony (CDR0060), the presence of the regulated waaP gene
was conﬁrmed by colony PCR using primers PaaraC and
waaPoutf.
CellulardepletionofLPSkinasesfromstrainsCDR0031and
CDR0060. Cultures of wild-type PAO1, CDR0031 (gentamicin,
100 g/l), and CDR0060 (carbenicillin, 300 g/l), with 0.2%
L-arabinoseaddedforCDR0031andCDR0060,weregrownover-
night. These were then subcultured into fresh medium (with and
without 0.2% L-arabinose) to a starting optical density at 600 nm
(OD600) of 0.01 (CDR0060) or 0.02 (PAO1 and CDR0031).
Growth was monitored by OD600 over time. Typically, growth of
the arabinose-dependent CDR0031 and CDR0060 cultures sub-
stantially leveled off at an OD600 of ~0.4 (at 5 h) in arabinose-free
medium, compared to the wild-type PAO1 strain or CDR0031
andCDR0060inarabinose-containingcultures,whichcontinued
to grow normally (Fig. 2). Presumably, culture growth leveled off
due to the gradual depletion of the kinase proteins during cell
doublings. For characterization of cells depleted of WaaP or
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(at 3,000  g, 10 min) from cultures without L-arabinose after
levelingofftoanOD600of~0.4(5h).Forcomparisons,cellsfrom
wild-typePAO1cultureswerealwaysharvestedatasimilarOD600
as that of LPS kinase-depleted cells.
Total LPS isolation and analysis by SDS-PAGE. Wild-type
PAO1, CDR0031, and CDR0060 were grown and harvested as
described above. Cell pellets were resuspended in 10 mM Tris-
HCl (pH 8.0) containing 2 mM MgCl2, DNase (100 g/ml), and
RNase (25 g/ml) and lysed in a French pressure cell (2 passes at
15,000lb/in2).TotalLPSwasisolatedaspreviouslydescribed(49).
LPS samples were analyzed after being resolved by SDS-PAGE in
precast12%bis-TrisNuPAGEgels(Invitrogen)andvisualizedby
silver staining (Bio-Rad).
Sarkosyl-extractedOMpreparationandLPSisolation.Outer
membranes were prepared as described previously (50, 51) from
cells prepared and lysed as described above. Unbroken cells were
removed by low-speed centrifugation (at 3,000  g, 10 min), and
theIMwassolubilizedbyadditionof1%Sarkosylandincubation
f o r1ha t30°C. OM was isolated by centrifugation at 100,000  g
for 1 h and resuspended in 10 mM Tris-HCl (pH 8.0). Proteins
were removed from isolated OM by digestion with proteinase K
(200 g/ml) overnight at 37°C. LPS was analyzed as described
above.
Sucrose density gradient separation of IM and OM and LPS
isolation. Cell pellets were resuspended in cold 20% (wt/vol) su-
crose in 10 mM Tris-HCl (pH 8.0), 50 g/ml DNase I, and frozen
at 80°C. Cell lysate was prepared as described above, and sepa-
rationofIMandOMwascarriedoutasdescribedpreviously(52).
Brieﬂy, overnight ultracentrifugation (260,000  g) of the cell
lysate over a 2-step sucrose gradient of 4 ml 70% (wt/vol) sucrose
cushion layered with 4 ml 60% (wt/vol) sucrose separated IM
(reddish) and OM (white) fractions. IM and OM fractions were
collected separately and diluted with water to a ﬁnal sucrose con-
centration of 20% and centrifuged again (260,000  g,1h )t o
pellet membranes. For crude LPS isolation, IM or OM samples
were resuspended in water and digested with proteinase K (0.25
g/l)in1NuPAGEloadingbuffer(Invitrogen)for3hat60°C.
IM or OM LPS was analyzed as described above.
Phosphorylation of LPS using [-33P]ATP and puriﬁed
P. aeruginosa WaaP. Kinase reaction mixtures (15 l total) con-
tained 20 mM Tris-HCl (pH 7.5), 15 mM MgCl2, 1 mM dithio-
threitol(DTT),1.0Ci[-33P]ATPdilutedwith10Munlabeled
ATP, and ~3.5 g total LPS isolated from wild-type PAO1,
CDR0031,andCDR0060,depletedofLPSkinases.Reactionswere
initiated by addition of 750 ng puriﬁed P. aeruginosa WaaP (see
Text S1 in the supplemental material), reaction mixtures were
incubated for2ha troom temperature, and reactions were
stopped by addition of 5 l4  NuPAGE sample loading buffer
(Invitrogen). For separation of LPS species after incubation with
WaaP(orwater),thetotalvolumeofeachkinasereactionmixture
was loaded on a 10-well precast 12% bis-Tris NuPAGE gel (Invit-
rogen) run at 200 V for 45 min, followed by drying of the gel for
45 min at 80°C. Incorporation of [-33P]ATP into LPS was de-
tected by exposure of the gel to Kodak BioMax XAR ﬁlm for 30 h
and development with a Kodak X-OMAT 2000A ﬁlm processor.
Lipid A isolation. Lipid A was isolated from cell pellets based
on a previous protocol (53) (see details in Text S1 in the supple-
mental material) and stored at 20°C until needed. For IM and
OMsamples,thepooledIMorOMfractionsfromsucrosedensity
gradient centrifugation were directly hydrolyzed with 1% acetic
acid to release the lipid A and then extracted with chloroform (as
described in Text S1). The samples contain both phospholipids
and lipid A.
ESI-MS of lipid A. Lipid A mass spectra were acquired on a
4000 QTRAP hybrid triple-quadrupole linear ion trap mass spec-
trometer equipped with a Turbo V ion source (Applied Biosys-
tems, Foster City, CA) utilizing the TurboIonSpray probe for ESI
(full method details in Text S1 in the supplemental material).
Brieﬂy, spectra were collected in the negative-ion mode over a
full-scan m/z from 60 to 2,200 with a quadrupole 3 (Q3) scan
(0.2-atomic-mass-unit [amu] step size, 4.3 s/scan, acquired for 1
to 4 min/sample). To determine each peak’s exact mass with iso-
topic resolution, the default enhanced-resolution scan was em-
ployed(acquisitiontime,1to4min/sample),centeredonthem/z
for the peak of interest. With exact masses identiﬁed for peaks of
interest, tandem MS spectra were acquired with the default prod-
uct ion (MS2) scan of the appropriate m/z range for each species
(0.1- to 0.2-amu step size, 1 to 5 s/scan, acquisition time of 1 to 4
min/sample). Data acquisition and analysis were performed with
Analyst 1.4.2 software (Applied Biosystems).
ESI-MS of LPS core. To isolate the core oligosaccharide, IM
LPS samples (isolated as described above from 500-ml cultures;
OD600of0.4to0.5)wereincubatedwith1.5%aceticacidfor2hat
100°C (ﬁnal volume, 1 ml), cooled to room temperature, and
centrifuged(16,200g,10min)topellettheaggregatedfreelipid
A released by mild acid hydrolysis. The supernatant, containing
the core, was removed and stored at 80°C until needed. For
ESI-MSanalysis,thesamplescontainingthefreecorewerethawed
and diluted (generally 5- to 50-fold, as needed) with water to a
volume of 500 l and piperidine was added to a ﬁnal concentra-
tion of 1% (vol/vol). Each sample was analyzed with ESI-MS as
described for lipid A (see Text S1 in the supplemental material)
withminormodiﬁcations:declusteringpotential(DP)was60V
and the nebulizer gas (GS1) was 35 lb/in2. Enhanced-resolution
and tandem MS were then performed as described for lipid A.
Data acquisition and analysis utilized Analyst 1.4.2 software (Ap-
plied Biosystems).
Electronmicroscopy.CellswereharvestedatanOD600of~0.4
and ﬁxed with a mixture of 2.5% glutaraldehyde and 2% parafor-
maldehyde in 0.1 M sodium cacodylate buffer (CB), pH 7.4, for
2 h at room temperature. Chemically ﬁxed samples were washed
in 0.1 M CB and postﬁxed with 1% osmium tetroxide (OsO4)-
1.5% potassium ferricyanide (K3[Fe(CN6)]) for 1 h, washed in
waterthreetimes,andincubatedin1%aqueousuranylacetatefor
1 h and dehydrated in ascending grades of ethanol. The samples
weretheninﬁltratedandembeddedinTAABEpon(MarivacCan-
ada Inc., St. Laurent, Canada) and polymerized at 60°C for 48 h.
Ultrathinsections(60to80nm)werecut,stainedwithleadcitrate,
and observed at 80 kV in a JEOL 1200EX transmission electron
microscope. Images were recorded using an AMT 2k charge-
coupled device (CCD) camera. Methods for HPF-substitution
TEM are described in Text S1 in the supplemental material.
MIC determinations. MIC values were determined according
to Clinical and Laboratory Standards Institute guidelines (54)
withthefollowingmodiﬁcation.TheBBLPromptkit(Difco)was
used according to the provided protocol to prepare an inoculum
of 1.5  108 CFU/ml from stationary-phase cells, which corre-
spondstoaMcFarlandturbiditystandardof0.5.Lbrothwasused
instead of Mueller-Hinton broth, and L-arabinose was added, as
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CDR0060. Growth was assessed after approximately 18 h at 37°C.
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